Bradycardia, Sick Sinus Syndrome and AV Block
How slow heart rhythms are evaluated and when monitoring, medication changes or a pacemaker may be considered.
Bradycardia means that the heart rate is slower than expected for the clinical situation. It may be normal during sleep or in trained athletes, but it can also result from sinus-node disease, atrioventricular block, medicines, electrolyte disturbance or other medical conditions.
Symptoms and Diagnosis
Concerning symptoms include fainting, near-fainting, dizziness, unexplained fatigue, breathlessness and exercise intolerance. The relation between symptoms and rhythm is central to decision-making. ECG, Holter or longer monitoring, blood tests and sometimes exercise testing are used to define the mechanism and exclude reversible causes.
Pacemaker Decisions
A pacemaker is considered when clinically important symptoms are linked to persistent or intermittent bradycardia, or when high-grade conduction disease creates significant risk. The decision is not based on one pulse measurement alone. Device type is selected according to the conduction problem, atrial rhythm, ventricular function and anticipated pacing requirement.
Call emergency services for fainting with injury, persistent severe weakness, chest pain, marked breathlessness or signs of poor circulation.
Clinical Depth and Risk Assessment
Risk is not defined by the diagnostic label alone. Symptoms, ECG and rhythm findings, ventricular function, myocardial scar or structural change, family history, associated disease and previous events are integrated. Genetic results, when relevant, require expert interpretation; a variant of uncertain significance is not equivalent to a diagnosis.
Diagnostic Strategy and Limitations
Testing is selected to answer a specific question. ECG, ambulatory monitoring, echocardiography, cardiac MRI, CT, laboratory testing, exercise assessment or invasive evaluation have complementary roles. A normal test may not exclude an intermittent disorder, while an abnormal measurement must be checked against technical quality and clinical probability.
Treatment Decision Framework
Treatment may combine risk-factor control, condition-specific medicines, rhythm or heart-failure therapy, catheter procedures, surgery and implanted devices. These options address different mechanisms and are not automatically substitutes for one another. Expected benefit, uncertainty, procedural burden and the patient’s informed preferences should be discussed explicitly.
Long-Term Follow-up
Follow-up assesses symptoms, exercise capacity, rhythm burden, ventricular function and treatment tolerance over time. Family screening may be appropriate in inherited or suspected inherited disease. New fainting, sustained rapid rhythm, chest pain, neurological symptoms or rapidly worsening breathlessness requires urgent assessment.
Questions to Discuss With the Cardiology Team
- Which finding has the greatest influence on my present risk?
- Which test or treatment would genuinely change management?
- What symptoms should lead to an earlier appointment or emergency care?
- Do relatives need clinical or genetic assessment?
Medical Information Note
This page supports an informed discussion with the clinical team. It does not provide a personal diagnosis, medicine dose or sports-clearance decision.